In the US, Roferon-A (interferon alfa-2a systemic) is a member of the drug class antineoplastic interferons and is used to treat Chronic Myelogenous Leukemia, Hairy Cell Leukemia, Hepatitis C, Kaposi's Sarcoma, Lymphoma and Renal Cell Carcinoma.
- ROFERON-A 3 MILLION INTERNATIONAL UNITS (IU) SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE (Leaflet)
- ROFERON-A 4.5 MILLION INTERNATIONAL UNITS (IU) SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE (Leaflet)
- ROFERON-A 6 MILLION INTERNATIONAL UNITS (IU) SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE (Leaflet)
- ROFERON-A 9 MILLION INTERNATIONAL UNITS (IU) SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE (Leaflet)
Ingredient matches for Roferon-A
Interferon Alfa-2a is reported as an ingredient of Roferon-A in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Czech Republic
- New Zealand
- Saudi Arabia
- South Africa
- United Arab Emirates
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.